Prelude Therapeutics (PRLD) Leases (2024 - 2025)
Prelude Therapeutics' Leases history spans 2 years, with the latest figure at $27.9 million for Q2 2025.
- For Q2 2025, Leases rose 4691.08% year-over-year to $27.9 million; the TTM value through Jun 2025 reached $27.9 million, up 4691.08%, while the annual FY2024 figure was $523000.0, N/A changed from the prior year.
- Leases for Q2 2025 was $27.9 million at Prelude Therapeutics, down from $28.3 million in the prior quarter.
- Across five years, Leases topped out at $30.1 million in Q1 2024 and bottomed at $523000.0 in Q4 2024.